 |
|
The influence of DNA polymorphism of multidrug resistant 1 (MDR1) on the effect of midazolam pretreatment in children
Hyo-Jin Byon, Keun-Suk Park, Yong-Hee Park, Jin-Tae Kim, Chul-Woo Jung, Hee-Soo Kim
Korean J Anesthesiol. 2012;62(4):332-336. Published online 2012 Apr 23 DOI: https://doi.org/10.4097/kjae.2012.62.4.332
|
|
Citations to this article as recorded by
 Mechanisms and implications in gene polymorphism mediated diverse reponses to sedatives, analgesics and muscle relaxants
Yan Sun, Hongyu Zhu, Elham Esmaeili, Xue Tang, Zhilin Wu
Korean Journal of Anesthesiology.2023; 76(2): 89. CrossRef The Role of Pharmacogenetics in Personalizing the Antidepressant and Anxiolytic Therapy
Milica Radosavljevic, Dubravka Svob Strac, Jasna Jancic, Janko Samardzic
Genes.2023; 14(5): 1095. CrossRef Influence of midazolam-related genetic polymorphism on conscious sedation during upper gastrointestinal endoscopy in a Korean population
Jae Yong Park, Beom Jin Kim, Sang Wook Lee, Hyun Kang, Jeong Wook Kim, In-Jin Jang, Jae Gyu Kim
Scientific Reports.2019;[Epub] CrossRef Correlation of MDR1 gene polymorphisms with anesthetic effect of sevoflurane–remifentanil following pediatric tonsillectomy
Nian-Jun Shi, Wei-Xia Zhang, Ning Zhang, Li-Na Zhong, Ling-Ping Wang
Medicine.2017; 96(24): e7002. CrossRef Sufentanil and Midazolam Dosing and Pharmacogenetic Factors in Pediatric Analgosedation and Withdrawal Syndrome
K. HRONOVÁ, P. POKORNÁ, L. POSCH, O. SLANAŘ
Physiological Research.2016; : S463. CrossRef
|